Palatal mucormycosis in patients with hematologic malignancy and stem cell transplantation

References

• Bonifaz A, Macias B, Paredes-Farrera F, . Palatal zygomycosis: experience of 21 cases. Oral Dis 2008; 14: 569–574.
   PubMedGoogle Scholar
• Kyrmizakis DE, Doxas PG, Hajiioannou JK, Papadakis CE. Palate ulcer due to mucormycosis. J Laryngol Otol 2002; 116: 146–147.
   PubMedGoogle Scholar
• Van der Westhuijzen AJ, Grotepass FW, Wyma G, Padayachee A. A rapidly fatal palatal ulcer: rhinocerebral mucormycosis. Oral Surg Oral Med Oral Pathol 1989; 68: 32–36.
   PubMedGoogle Scholar
• Damante JH, Fleury RN. Oral and rhino-orbital mucormycosis: case report. J Oral Maxillofac Surg 1998; 56: 267–271.
   PubMedGoogle Scholar
• Pandey A, George J, Rao NN. Mucormycosis causing extensive destruction of maxilla. Indian J Dent Res 2004; 15: 74–77.
   PubMedGoogle Scholar
• Tugsel Z, Sezer B, Akalin T. Facial swelling and palatal ulceration in a diabetic patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 630–636.
   PubMed Web of Science ®Google Scholar
• Huang JS, Kok SH, Lee JJ, . Extensive maxillary sequestration resulting from mucormycosis. Br J Oral Maxillofac Surg 2005; 43: 532–534.
   PubMedGoogle Scholar
• Hyatt DS, Young YM, Haynes KA, . Rhinocerebral mucormycosis following bone marrow transplantation. J Infect 1992; 24: 67–71.
   PubMedGoogle Scholar
• Rosenberg SW, Lepley JB. Mucormycosis in leukemia. Oral Surg Oral Med Oral Pathol 1982; 54: 26–32.
   PubMedGoogle Scholar
• Mohammed S, Sahoo TP, Jayshree RS, Bapsy PP, Hema S. Sino-oral zygomycosis due to Absidia corymbifera in a patient with acute leukemia. Med Mycol 2004; 42: 475–478.
   PubMed Web of Science ®Google Scholar
• Piccin A, Russell JD, Fleming P, . Invasive rhino-maxillary mucormycosis diagnosed before HSCT. Pediatr Blood Cancer 2008; 50: 393–395.
   PubMedGoogle Scholar
• Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J 2004; 83: 556, 558–560, 562.
   PubMedGoogle Scholar
• Abuali MM, Posada R, Del Toro G, . Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol 2009; 47: 4176–4179.
   PubMedGoogle Scholar
• Safar A, Marsan J, Marglani O, . Early identification of rhinocerebral mucormycosis. J Otolaryngol 2005; 34: 166–171.
   PubMedGoogle Scholar
• Meyers BR, Wormser G, Hirschman SZ, Blitzer A. Rhinocerebral mucormycosis: premortem diagnosis and therapy. Arch Intern Med 1979; 139: 557–560.
   PubMedGoogle Scholar
• Bodey GP. Fungal infections complicating acute leukemia. J Chronic Dis 1966; 19: 667–687.
   PubMedGoogle Scholar
• Kumar L, Singh S, Aggarwal S, . Phycomycosis infection in acute leukaemia. J Assoc Physicians India 1990; 38: 787–789.
   PubMedGoogle Scholar
• Ryan M, Yeo S, Maguire A, . Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia. Eur J Pediatr 2001; 160: 235–238.
   PubMed Web of Science ®Google Scholar
• Maiorano E, Favia G, Capodiferro S, Montagna MT, Lo Muzio L. Combined mucormycosis and aspergillosis of the oro-sinonasal region in a patient affected by Castleman disease. Virchows Arch 2005; 446: 28–33.
   PubMedGoogle Scholar
• Marchevsky AM, Bottone EJ, Geller SA, Giger DK. The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol 1980; 11: 457–464.
   PubMed Web of Science ®Google Scholar
• Anstead GM, Sutton DA, Thompson EH, . Disseminated zygomycosis due to Rhizopus schipperae after heatstroke. J Clin Microbiol 1999; 37: 2656–2662.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236–301.
   PubMed Web of Science ®Google Scholar
• Roden MM, Zaoutis TE, Buchanan WL, . Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634–653.
   PubMed Web of Science ®Google Scholar
• Pagano L, Offidani M, Fianchi L, . Mucormycosis in hematologic patients. Haematologica 2004; 89: 207–214.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30: 851–856.
   PubMed Web of Science ®Google Scholar
• McNulty JS. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope 1982; 92: 1140–1143.
   PubMedGoogle Scholar
• Mnif N, Hmaied E, Oueslati S, . Imaging of rhinocerebral mucormycosis. J Radiol 2005; 86: 1017–1020.
   PubMedGoogle Scholar
• Karabulut AB, Kabakas F, Berköz O, Karakas Z, Kesim SN. Hard palate perforation due to invasive aspergillosis in a patient with acute lymphoblastic leukemia. Int J Pediatr Otorhinolaryngol 2005; 69:1395–1398.
   PubMedGoogle Scholar
• Ferry AP, Abedi S. Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases. Ophthalmology 1983; 90: 1096–1104.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006; 20: 581–607.
   PubMed Web of Science ®Google Scholar
• Hamer EC, Moore CB, Denning DW. Comparison of two fluorescent whiteners, calcofluor and blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory. Clin Microbiol Infect 2006; 12: 181–184.
   PubMed Web of Science ®Google Scholar
• McDermott NE, Barrett J, Hipp J, Merino MJ, Richard Lee CC, Waterman P, . Successful treatment of periodontal mucormycosis: report of a case and literature review. Oral surg Oral Med oral Pathol Oral Radiol Ended. 2010;109(3): e64–69.
   Google Scholar
• Tryfon S, Stanopoulos I, Kakavelas E, Nikolaidou A, Kioumis I. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: a case report. J Oral Maxillofac Surg 2002; 60: 328–330.
   PubMedGoogle Scholar
• Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 1997; 107: 855–862.
   PubMed Web of Science ®Google Scholar
• Ruoppi P, Dietz A, Nikanne E, . Paranasal sinus mucormycosis: a report of two cases. Acta Otolaryngol 2001; 121: 948–952.
   PubMed Web of Science ®Google Scholar
• Hendrickson RG, Olshaker J, Duckett O. Rhinocerebral mucormycosis: a case of a rare, but deadly disease. J Emerg Med 1999; 17: 641–645.
   PubMedGoogle Scholar
• Tidwell J, Higuera S, Hollier LH Jr. Facial reconstruction after mucormycosis in an immunocompetent host. Am J Otolaryngol 2005; 26: 333–336.
   PubMedGoogle Scholar
• Talmi YP, Goldschmied-Reouven A, Bakon M, . Rhino-orbital and rhino-orbitocerebral mucormycosis. Otolaryngol Head Neck Surg 2002; 127: 22–31.
   PubMed Web of Science ®Google Scholar
• Pelton RW, Peterson EA, Patel BC, Davis K. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthal Plast Reconstr Surg 2001; 17: 62–66.
   PubMed Web of Science ®Google Scholar
• Bengel D, Susa M, Schreiber H, Ludolph AC, Tumani H. Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequence. Eur J Neurol 2007; 14: 1067–1070.
   PubMed Web of Science ®Google Scholar
• Petrikkos G, Skiada A, Sambatakou H, . Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 22: 753–756.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Spreghini E, Santinelli A, . Posaconazole prophylaxis in experimental systemic zygomycosis. Antimicrob Agents Chemother 2007; 51: 73–77.
   PubMedGoogle Scholar
• Alexander BD, Perfect JR, Daly JS, . Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Transplantation 2008; 86: 791–796.
   PubMed Web of Science ®Google Scholar
• Raj P, Vella EJ, Bickerton RC. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin – a case report. J Laryngol Otol 1998; 112: 367–370.
   PubMedGoogle Scholar
• Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000; 33: 349–365.
   PubMed Web of Science ®Google Scholar
• Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994; 39: 3–22.
   PubMed Web of Science ®Google Scholar
• John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005; 11: 515–517.
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Simitsopoulou M, Roilides E, . Interferon-gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 2005; 191: 1180–1187.
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Walsh TJ. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J 2004; 23: 769–773.
   PubMed Web of Science ®Google Scholar
• Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993; 11: 383–388.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18: 556–569.
   PubMed Web of Science ®Google Scholar
• Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004; 17: 517–525.
   PubMed Web of Science ®Google Scholar